ASGR1 and steatosis: However, ASGR1 deficient mice, in the same study showed additional metabolic changes related to increased activation of AMP-activated protein kinase (AMPK), which plays a role in suppressing hepatic fatty acid synthesis by inhibiting SREBP-1c, thus preventing the adverse effects of steatosis [19].